FDA Announces Conference on Global Medical Quality Systems Sept. 10-12
The Food and Drug Administration, in cosponsorship with Parenteral Drug Association (PDA), announced a public conference Sept.10-12 in Baltimore on "Compliance Through Quality Systems: Implementing and Advancing a Sustainable Global Quality Culture." The conference will cover issues affecting the industry and explore strategies and approaches for ensuring conformance with regulations to facilitate the development and continuous improvement of safe and effective medical products, FDA said.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
According to FDA, the conference establishes a unique forum to discuss the foundations, emerging technologies and innovations in regulatory science, as well as the current quality and compliance areas of concerns. Meeting participants will hear from FDA and industry speakers about the requirements and best practices to consider while implementing robust quality systems in order to deliver the best quality product. FDA said it encourages attendees to register at their earliest convenience. Online registration is available here. FDA said on-site registration will also be available.